Abstract
A new radiopharmaceutical, merisoprol Hg 197, permits visualization of the spleen with a reliability, speed, and simplicity hitherto impossible with other agents. Forty-two scintiscans performed on 35 patients have proved useful in assessing splenic size, shape, and position, in demonstrating focal abnormalities, and in differentiating left upper abdominal masses. In this group, however, the spleen scan has played its most valuable role as a sensitive method of following splenic response to therapeutic regimens in those patients suffering from disorders of the hematopoietic system. Morbidity incident to spleen scanning with this new agent was nil.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
